GAMMA Investing
STLN icon

GAMMA Investing’s Starling Oncology STLN Stock Holding History

GAMMA Investing’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.41K Buy
381
+318
+505% +$1.9K ﹤0.01% 3893
2026
Q2 		$342 Hold
63
– – ﹤0.01% 4033
2026
Q1 		$193 Sell
63
-97
-61% -$297 ﹤0.01% 4059
2025
Q4 		$570 Buy
+160
New +$593 ﹤0.01% 3896

Other funds holding STLN

Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Berkshire Money Management
Berkshire Money Management Dalton, Massachusetts $1.16B AUM 13.8% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

GAMMA Investing's STLN Position: Q3 2026 in Review

GAMMA Investing increased its Starling Oncology (STLN) stake by 505% in Q3 2026, buying an estimated $1.9K and bringing the position to 381 shares worth $2.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3893.

GAMMA Investing first reported a position in STLN in Q4 2025 and has held it in 4 quarters since. 25 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • GAMMA Investing held 381 shares of Starling Oncology worth $2.41K as of Q3 2026.
  • GAMMA Investing bought 318 Starling Oncology shares in Q3 2026, an estimated $1.9K.
  • Starling Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3893 holding.
  • GAMMA Investing first reported a position in Starling Oncology in Q4 2025 and has held it in 4 quarters since.
  • 25 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.